These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 27748842)

  • 21. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
    Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
    Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Critical role for the long non-coding RNA AFAP1-AS1 in the proliferation and metastasis of hepatocellular carcinoma.
    Lu X; Zhou C; Li R; Liang Z; Zhai W; Zhao L; Zhang S
    Tumour Biol; 2016 Jul; 37(7):9699-707. PubMed ID: 26803513
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel long noncoding RNA HHIP-AS1 suppresses hepatocellular carcinoma progression through stabilizing HHIP mRNA.
    Bo C; Li X; He L; Zhang S; Li N; An Y
    Biochem Biophys Res Commun; 2019 Dec; 520(2):333-340. PubMed ID: 31604528
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overexpression of the long non-coding RNA SPRY4-IT1 promotes tumor cell proliferation and invasion by activating EZH2 in hepatocellular carcinoma.
    Zhou M; Zhang XY; Yu X
    Biomed Pharmacother; 2017 Jan; 85():348-354. PubMed ID: 27899259
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long Noncoding RNA GATA3-AS1 Promotes Cell Proliferation and Metastasis in Hepatocellular Carcinoma by Suppression of PTEN, CDKN1A, and TP53.
    Luo X; Zhou N; Wang L; Zeng Q; Tang H
    Can J Gastroenterol Hepatol; 2019; 2019():1389653. PubMed ID: 31871924
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High expression of long non-coding RNA ANRIL is associated with poor prognosis in hepatocellular carcinoma.
    Hua L; Wang CY; Yao KH; Chen JT; Zhang JJ; Ma WL
    Int J Clin Exp Pathol; 2015; 8(3):3076-82. PubMed ID: 26045820
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Down-regulation of long non-coding RNA GAS5-AS1 and its prognostic and diagnostic significance in hepatocellular carcinoma.
    Wang Y; Jing W; Ma W; Liang C; Chai H; Tu J
    Cancer Biomark; 2018; 22(2):227-236. PubMed ID: 29660898
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long noncoding RNA AFAP1-AS1 indicates a poor prognosis of hepatocellular carcinoma and promotes cell proliferation and invasion via upregulation of the RhoA/Rac2 signaling.
    Zhang JY; Weng MZ; Song FB; Xu YG; Liu Q; Wu JY; Qin J; Jin T; Xu JM
    Int J Oncol; 2016 Apr; 48(4):1590-8. PubMed ID: 26892468
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The long noncoding RNA, EGFR-AS1, a target of GHR, increases the expression of EGFR in hepatocellular carcinoma.
    Qi HL; Li CS; Qian CW; Xiao YS; Yuan YF; Liu QY; Liu ZS
    Tumour Biol; 2016 Jan; 37(1):1079-89. PubMed ID: 26271667
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long non-coding RNA TUG1 is up-regulated in hepatocellular carcinoma and promotes cell growth and apoptosis by epigenetically silencing of KLF2.
    Huang MD; Chen WM; Qi FZ; Sun M; Xu TP; Ma P; Shu YQ
    Mol Cancer; 2015 Sep; 14():165. PubMed ID: 26336870
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long noncoding RNA glypican 3 (GPC3) antisense transcript 1 promotes hepatocellular carcinoma progression via epigenetically activating GPC3.
    Zhu XT; Yuan JH; Zhu TT; Li YY; Cheng XY
    FEBS J; 2016 Oct; 283(20):3739-3754. PubMed ID: 27573079
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Small nucleolar RNA 47 promotes tumorigenesis by regulating EMT markers in hepatocellular carcinoma.
    Li G; He Y; Liu X; Zheng Z; Zhang M; Qin F; Lan X
    Minerva Med; 2017 Oct; 108(5):396-404. PubMed ID: 28466632
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long non-coding RNA CARLo-5 expression is associated with disease progression and predicts outcome in hepatocellular carcinoma patients.
    Wang F; Xie C; Zhao W; Deng Z; Yang H; Fang Q
    Clin Exp Med; 2017 Feb; 17(1):33-43. PubMed ID: 26433964
    [TBL] [Abstract][Full Text] [Related]  

  • 34. LncRNA SOX21-AS1 is associated with progression of hepatocellular carcinoma and predicts prognosis through epigenetically silencing p21.
    Wei C; Wang H; Xu F; Liu Z; Jiang R
    Biomed Pharmacother; 2018 Aug; 104():137-144. PubMed ID: 29772433
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long noncoding RNA FTX inhibits hepatocellular carcinoma proliferation and metastasis by binding MCM2 and miR-374a.
    Liu F; Yuan JH; Huang JF; Yang F; Wang TT; Ma JZ; Zhang L; Zhou CC; Wang F; Yu J; Zhou WP; Sun SH
    Oncogene; 2016 Oct; 35(41):5422-5434. PubMed ID: 27065331
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long Noncoding RNA (lncRNA) Small Nucleolar RNA Host Gene 16 (SNHG16) Predicts Poor Prognosis and Sorafenib Resistance in Hepatocellular Carcinoma.
    Guo Z; Zhang J; Fan L; Liu J; Yu H; Li X; Sun G
    Med Sci Monit; 2019 Mar; 25():2079-2086. PubMed ID: 30893293
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RRAD inhibits aerobic glycolysis, invasion, and migration and is associated with poor prognosis in hepatocellular carcinoma.
    Shang R; Wang J; Sun W; Dai B; Ruan B; Zhang Z; Yang X; Gao Y; Qu S; Lv X; Tao K; Wang L; Dou K; Wang D
    Tumour Biol; 2016 Apr; 37(4):5097-105. PubMed ID: 26546438
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Poor expression of long-chain noncoding RNA GAPLINC inhibits epithelial-mesenchymal transition, and invasion and migration of hepatocellular carcinoma cells.
    Zhang W; Yao H; Wu Y
    Anticancer Drugs; 2019 Sep; 30(8):784-794. PubMed ID: 31415284
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The long non-coding RNA AK001796 contributes to poor prognosis and tumor progression in hepatocellular carcinoma.
    Han QL; Chen BT; Zhang KJ; Xia ST; Zhong WW; Zhao ZM
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2013-2019. PubMed ID: 30915744
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of long noncoding RNAs biomarkers in patients with hepatitis B virus-associated hepatocellular carcinoma.
    Mou Y; Wang D; Xing R; Nie H; Mou Y; Zhang Y; Zhou X
    Cancer Biomark; 2018; 23(1):95-106. PubMed ID: 29991128
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.